Z Hao1, H Münzberg1, K Rezai-Zadeh1, M Keenan2, D Coulon2, H Lu3, H-R Berthoud1, J Ye1. 1. Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA. 2. Louisiana State University Agricultural Center, Baton Rouge, LA, USA. 3. Department of Endocrinology & Metabolism, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China.
Abstract
OBJECTIVE: Weight regain contributes to the therapeutic failure in 15-20% of type 2 diabetic patients after Roux-en-Y gastric bypass surgery (RYGB), and the mechanism remains largely unknown. This study was conducted to explore the mechanism of weight regain. RESEARCH DESIGN: Wild-type (WT) diet-induced obese (DIO) mice were used to mimic human obesity, and ob/ob mice were used for leptin deficiency-induced obesity. Two groups of mice were compared in weight regain for 10 months after RYGB. Weight loss, food intake, fecal energy loss and energy expenditure were monitored in the study of weight regain. Fasting insulin, insulin tolerance and homeostatic model assessment-insulin resistance were tested for insulin sensitivity under the weight regain. Weight loss from RYGB and calorie restriction was compared for the impact in insulin sensitivity. RESULTS: In WT mice, RYGB induced a sustained weight loss and insulin sensitization over the sham operation in this 10-month study. However, RYGB failed to generate the same effects in leptin-deficient ob/ob mice, which suffered a weight regain over the pre-surgery level. In ob/ob mice, body weight was reduced by RYGB transiently in the first week, recovered in the second week and increased over the baseline thereafter. Weight loss was induced by RYGB relative to that of sham mice, but the loss was not sufficient to keep body weight below the pre-surgery levels. In addition, insulin sensitivity was not improved by the weight loss. The response to RYGB was improved in ob/ob mice by 2 weeks of leptin treatment. Weight loss from calorie restriction had an equivalent effect on insulin sensitization compared with that of RYGB. CONCLUSION: Those data demonstrate that ob/ob mice and DIO mice responded differently to RYGB surgery, suggesting that leptin may be one of the factors required for RYGB to prevent weight regain and diabetes recurrence.
OBJECTIVE: Weight regain contributes to the therapeutic failure in 15-20% of type 2 diabeticpatients after Roux-en-Y gastric bypass surgery (RYGB), and the mechanism remains largely unknown. This study was conducted to explore the mechanism of weight regain. RESEARCH DESIGN: Wild-type (WT) diet-induced obese (DIO) mice were used to mimic humanobesity, and ob/ob mice were used for leptindeficiency-induced obesity. Two groups of mice were compared in weight regain for 10 months after RYGB. Weight loss, food intake, fecal energy loss and energy expenditure were monitored in the study of weight regain. Fasting insulin, insulin tolerance and homeostatic model assessment-insulin resistance were tested for insulin sensitivity under the weight regain. Weight loss from RYGB and calorie restriction was compared for the impact in insulin sensitivity. RESULTS: In WT mice, RYGB induced a sustained weight loss and insulin sensitization over the sham operation in this 10-month study. However, RYGB failed to generate the same effects in leptin-deficient ob/ob mice, which suffered a weight regain over the pre-surgery level. In ob/ob mice, body weight was reduced by RYGB transiently in the first week, recovered in the second week and increased over the baseline thereafter. Weight loss was induced by RYGB relative to that of sham mice, but the loss was not sufficient to keep body weight below the pre-surgery levels. In addition, insulin sensitivity was not improved by the weight loss. The response to RYGB was improved in ob/ob mice by 2 weeks of leptin treatment. Weight loss from calorie restriction had an equivalent effect on insulin sensitization compared with that of RYGB. CONCLUSION: Those data demonstrate that ob/ob mice and DIO mice responded differently to RYGB surgery, suggesting that leptin may be one of the factors required for RYGB to prevent weight regain and diabetes recurrence.
Authors: Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap Journal: N Engl J Med Date: 2014-03-31 Impact factor: 91.245
Authors: Ida J Hatoum; Nicholas Stylopoulos; Amanda M Vanhoose; Kelli L Boyd; Deng Ping Yin; Kate L J Ellacott; Lian Li Ma; Kasia Blaszczyk; Julia M Keogh; Roger D Cone; I Sadaf Farooqi; Lee M Kaplan Journal: J Clin Endocrinol Metab Date: 2012-04-06 Impact factor: 5.958
Authors: Jianping Ye; Zheng Hao; Michael B Mumphrey; R Leigh Townsend; Laurel M Patterson; Nicholas Stylopoulos; Heike Münzberg; Christopher D Morrison; Daniel J Drucker; Hans-Rudolf Berthoud Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-01-15 Impact factor: 3.619
Authors: Tianyi Tang; Jin Zhang; Jun Yin; Jaroslaw Staszkiewicz; Barbara Gawronska-Kozak; Dae Young Jung; Hwi Jin Ko; Helena Ong; Jason K Kim; Randy Mynatt; Roy J Martin; Michael Keenan; Zhanguo Gao; Jianping Ye Journal: J Biol Chem Date: 2009-12-17 Impact factor: 5.157
Authors: H E Wilson-Pérez; A P Chambers; D A Sandoval; M A Stefater; S C Woods; S C Benoit; R J Seeley Journal: Int J Obes (Lond) Date: 2012-02-14 Impact factor: 5.095
Authors: Felicia Goldsmith; Justin Guice; Ryan Page; David A Welsh; Christopher M Taylor; Eugene E Blanchard; Meng Luo; Anne M Raggio; Rhett W Stout; Diana Carvajal-Aldaz; Amanda Gaither; Christine Pelkman; Jianping Ye; Roy J Martin; James Geaghan; Holiday A Durham; Diana Coulon; Michael J Keenan Journal: Mol Nutr Food Res Date: 2016-08-11 Impact factor: 5.914